论文部分内容阅读
对伴有腹腔播散的胃癌病人尚无标准的治疗方法。此研究调查姑息性手术后有可见残留病灶者进行腹腔内化疗的价值。 病人和方法:1994～1998年间49例符合病人,选择标准:组织学证实为胃腺癌、无血源性转移灶、ECOG东方临床肿瘤分级≤2、年龄≤65岁、未作过腹部手术、骨髓、肝、心和肾功能尚可,无其他严重的健康状况和活动性恶性肿瘤,未作过全身性化疗。姑息性切除包括胃切除术、广泛淋巴结切除和减癌细胞术(包括切除一邻近器官、腹膜切除或转移灶切
There is no standard treatment for gastric cancer with abdominal dissemination. This study investigated the value of intraperitoneal chemotherapy in patients with visible residual disease after palliative surgery. Patients and Methods: Between 1994 and 1998, 49 patients met the criteria of choice: histologically confirmed as gastric adenocarcinoma, no hematogenous metastasis, ECOG Oriental clinical grade ≤2, age ≤65 years, no abdominal surgery, bone marrow , Liver, heart and kidney function is acceptable, no other serious health conditions and active malignancies, no systemic chemotherapy. Palliative resection includes gastrectomy, extensive lymph node dissection, and cancer reduction (including resection of a nearby organ, peritoneum, or metastases